Enovix Corp (ENVX): Results of Operations and Financial Condition
Enovix Corp (ENVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Drones Drive Strong ENVX Revenue Growth New 2027 Revenue Guidance $65 Million to $85 Million $128 Million of 2030 Notes Retired Capturing a 36% Discount Restructuring Lowers Annual Cost by $8.5 Million FREMONT, Calif., November 12, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (“
How this was made
The 30-second read
Why it matters
The guidance expansion provides a fresh data point for traders evaluating the stock's upside potential.
Market read
New revenue guidance could drive short‑term buying interest in ENVX.
What to watch
The company's restructuring costs and debt retirement may constrain cash flow despite higher revenue.
Enovix Q3 2026 revenue of $11.0 million, up 38% year over year; new FY2027 revenue guidance of $65.0 – 85.0 million
Revenue grew 38% year over year and the non-GAAP gross margin reached 34.5%, but operating cash outflow rose, the smartphone qualification did not meet the energy-density target, and Q4 2026 guidance points to a non-GAAP operating loss of $28.0 – 31.0 million. Capital actions (2030 Notes repurchases, a warrant dividend, a 220-position restructuring) address the balance sheet and cost base, with their results still to come.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Revenue, Q3 2026 (GAAP and non-GAAP)GAAP | $11.04M | 22% | 38% |
| Gross profit, Q3 2026GAAP | $3.33M | – | $1.9 million |
| Gross margin, Q3 2026GAAP | 30.1% | – | 12.6pts |
| Gross profit, Q3 2026non-GAAP | $3.80M | – | $2.1 million |
| Gross margin, Q3 2026non-GAAP | 34.5% | – | 13.5pts |
| Cost of revenue, Q3 2026GAAP | $7.71M | – | – |
| Research and development expense, Q3 2026GAAP | $26.81M | – | – |
| Selling, general and administrative expense, Q3 2026GAAP | $15.81M | – | – |
| Total operating expenses, Q3 2026GAAP | $42.62M | – | $(5.8) million |
| Total operating expenses, Q3 2026non-GAAP | $33.02M | – | $1.5 million |
| Loss from operations, Q3 2026GAAP | −$39.29M | – | $7.7 million |
| Loss from operations, Q3 2026non-GAAP | −$29.21M | – | $0.6 million |
| Interest income, Q3 2026GAAP | $4.94M | – | – |
| Interest expense, Q3 2026GAAP | −$6.56M | – | – |
| Net loss attributable to Enovix, Q3 2026GAAP | −$41.95M | – | – |
| Net loss attributable to Enovix, Q3 2026non-GAAP | −$31.87M | – | – |
| Net loss per share, diluted, Q3 2026GAAP | $(0.19) | – | $0.08 |
| Net loss per share, basic, Q3 2026GAAP | $(0.19) | – | $0.07 |
| Net loss per share, diluted, Q3 2026non-GAAP | $(0.15) | – | $(0.01) |
| Net cash used in operating activities, Q3 2026GAAP | −$29.2M | – | $(3.7) million |
| Capital expenditures, Q3 2026GAAP | −$3.9M | – | $(0.9) million |
| Free cash flow, Q3 2026non-GAAP | −$33.1M | – | $(4.6) million |
| Adjusted EBITDA, Q3 2026non-GAAP | −$21.06M | – | $0.3 million |
| Cash, cash equivalents, marketable securities and restricted cash, as of October 4, 2026other | $512.2M | – | – |
| Revenue, nine months ended October 4, 2026 (YTD 2026)GAAP | $27.66M | – | $7.1 million |
| Gross profit, YTD 2026GAAP | $6.18M | – | $2.6 million |
| Gross margin, YTD 2026GAAP | 22.3% | – | 4.8pts |
| Gross profit, YTD 2026non-GAAP | $7.59M | – | $3.2 million |
| Gross margin, YTD 2026non-GAAP | 27.4% | – | 6.2pts |
| Total operating expenses, YTD 2026GAAP | $132.7M | – | $(4.2) million |
| Total operating expenses, YTD 2026non-GAAP | $94.34M | – | $5.6 million |
| Loss from operations, YTD 2026GAAP | −$126.5M | – | $6.8 million |
| Loss from operations, YTD 2026non-GAAP | −$86.75M | – | $(2.4) million |
| Net loss per share, diluted, YTD 2026GAAP | $(0.56) | – | $0.03 |
| Net loss per share, diluted, YTD 2026non-GAAP | $(0.41) | – | $(0.01) |
| Net cash used in operating activities, YTD 2026GAAP | −$84.1M | – | $(15.8) million |
| Capital expenditures, YTD 2026GAAP | −$16.7M | – | $0.5 million |
| Free cash flow, YTD 2026non-GAAP | −$100.8M | – | $(15.3) million |
| Adjusted EBITDA, YTD 2026non-GAAP | −$60.3M | – | $2.0 million |
Q4 2026 and fiscal year 2027, as of November 12, 2026 outlook
- RevenueQ4 2026: $9.0 – 10.0 million; FY 2027: $65.0 – 85.0 million
- NoteQ4 2026 revenue guidance $9.0 – 10.0 million; year-over-year change printed as (20%) – (12%) against Q4 2025 revenue of $11.3 million
- NoteQ4 2026 non-GAAP loss from operations guidance ($28.0 – 31.0) million; year-over-year change printed as 3% – (7%) against ($28.9) million
- NoteQ4 2026 non-GAAP net loss per share guidance ($0.13 – 0.17); year-over-year change printed as 7% – (21%) against ($0.14)
- NoteQ4 2026 capital expenditures guidance $5.0 – 8.0 million; Q4 2025 capital expenditures printed as $1.0 million; change printed as n/m
- NoteFY 2027 revenue guidance $65.0 – 85.0 million; FY 2026 revenue estimate $36.7 – 37.7 million (year-to-date revenue of $27.7 million plus Q4 2026 guidance, not separate guidance); year-over-year change printed as +75% – +128% against the $37.2 million midpoint
- NoteCompany states the FY 2027 midpoint is nearly double its expected 2026 revenue, and that nearly half the FY 2027 midpoint is already in backlog
- NoteGuidance excludes provisions for proposed tax law changes, future asset impairments, pending legal matters other than probable and estimable amounts, and investment, derivative and foreign currency gains or losses; the company gives no GAAP reconciliation for non-GAAP guidance, citing the unreasonable efforts exception
Capital returns
- Repurchased $6.2 million of common stock in Q3 2026 (cash flow statement shows $(6,213) thousand year to date)
- Repurchased another $15.5 million of common stock in October 2026
- Retired $128.0 million face value of 4.75% Convertible Senior Notes due 2030 for approximately $81.4 million since quarter end; the filing describes this as a 36% discount that cut debt by $46.6 million more than was paid
- The letter section states the market discount was approximately $47 million and will show up as profit in GAAP results but not in non-GAAP results
- Remaining 2030 Notes stand at $232.0 million
- Declared a warrant dividend of one warrant for every four shares of common stock; record date November 13, 2026; distribution expected on or about November 18, 2026; trading on Nasdaq as ENVXW
- Each warrant buys one share at $3.00, payable in cash or in 2028 Notes at full face value; expires April 28, 2028, or earlier if the stock trades at or above $3.30 for 20 of any 30 consecutive trading days
- Holders of 2028 Notes and 2030 Notes on the record date receive warrants on the same terms without converting, based on the shares into which their notes were convertible
- Company launched the warrant dividend designed to retire its 3.00% Convertible Senior Notes due 2028; the company states that it cannot predict whether or when holders will exercise
- Year-to-date repurchase of common stock printed as $(6,213) thousand against $(58,385) thousand in the prior-year period
What drove it
- Company states the higher Q3 2026 gross margin resulted from a richer revenue mix, including smart eyewear revenue and drone and defense revenue
- Company states drone and defense customers again drove the quarter; the drone, defense and industrial pipeline grew 18% to approximately $216 million from $183 million in the prior quarter, with drones accounting for $150 million
- Company reports a 100,000-battery purchase order for conventional cells from a multinational provider of dual-use drone systems, and an initial production order for MX1-B01 high-energy aerial drone cells from a U.S. drone manufacturer with initial deliveries scheduled in early 2027
- Company reports year-to-date smart eyewear shipments of approximately 19,000 units against a 50,000-pack backlog to be completed in the first half of 2027
- Company states that its 220-position restructuring in early November cut approximately $8.5 million of annual cost and rebalanced resources toward Korean operations
- Company states that its $19 million expansion to double drone battery capacity at its South Korean facility is underway and expected to come online in Q2 2027
- Company states that the AI-1 smartphone cell passed internal cell-level qualification, but the qualification was on the pre AI-2 version and did not meet the latest energy-density target of more than 1,000 watt-hrs/liter; the company decided not to proceed with system-level field testing with pre AI-2 units
- Company states that its lead smartphone OEM is expected to finish its parallel qualification next week
Concerns
- Net cash used in operating activities rose to $(29.2) million in Q3 2026 from $(25.5) million, and year-to-date to $(84.1) million from $(68.3) million
- Free cash flow was $(33.1) million in Q3 2026 against $(28.5) million a year earlier, and $(100.8) million year to date against $(85.5) million
- Q4 2026 revenue guidance of $9.0 – 10.0 million is printed as a year-over-year decline of (20%) – (12%) against Q4 2025 revenue of $11.3 million
- Q4 2026 non-GAAP loss from operations guidance of ($28.0 – 31.0) million; the company states that the FY 2027 guidance rests on backlog and pipeline conversion, and the risk factors list purchase order modification, delay or cancellation
- Smartphone qualification did not meet the energy-density target on the pre AI-2 version; the company decided not to proceed with system-level field testing with those units
- Total cash and investments decreased: cash and cash equivalents fell to $63,225 thousand from $106,014 thousand at December 28, 2025, and total equity fell to $171,143 thousand from $274,011 thousand
- The filing references a securities class action, with legal costs of $434 thousand in Q3 2026 and $2,823 thousand year to date treated as non-GAAP adjustments
- Forward-looking risk factors include customer concentration in defense and consumer technology markets, interim CEO arrangement, and reliance on the manufacturing process corrective actions for smart eyewear shipments
- The company states its warrant dividend exercise cannot be predicted, and the cash proceeds or debt retired may differ materially from its expectations
What to watch
- Q4 2026 revenue against the $9.0 – 10.0 million guidance range, and the non-GAAP loss from operations against ($28.0 – 31.0) million
- Conversion of the 100,000-battery drone order and the MX1-B01 initial production order into shipments in early 2027
- Completion of the 50,000-pack smart eyewear backlog in the first half of 2027 and the expected sampling of AI-2 with eyewear customers
- Outcome of the lead smartphone OEM parallel qualification the company said was expected to finish the following week
- Exercise of the ENVXW warrants following distribution on or about November 18, 2026, and the number of 2028 Notes retired through the warrant dividend
- Commissioning of the $19 million South Korea drone battery capacity expansion, expected in Q2 2027
- Realization of the approximately $8.5 million annual cost reduction from the 220-position restructuring
- Operating cash outflow and free cash flow trend in Q4 2026, given Q4 2026 capital expenditure guidance of $5.0 – 8.0 million
Balance sheet and cash flow
- Cash and cash equivalents $63,225 thousand as of October 4, 2026 (December 28, 2025: $106,014 thousand)
- Short-term investments $342,273 thousand (December 28, 2025: $406,026 thousand)
- Long-term investments $104,558 thousand (December 28, 2025: $106,810 thousand)
- Total assets $754,973 thousand (December 28, 2025: $878,975 thousand)
- Long-term debt, net $521,873 thousand (December 28, 2025: $519,271 thousand)
- Short-term debt $11,650 thousand (December 28, 2025: $9,865 thousand)
- Total liabilities $583,830 thousand (December 28, 2025: $604,964 thousand)
- Total equity $171,143 thousand (December 28, 2025: $274,011 thousand)
- Inventory $19,849 thousand (December 28, 2025: $13,617 thousand)
- Cash, cash equivalents and restricted cash at end of period $65,328 thousand (September 28, 2025: $337,519 thousand)
- Year-to-date net cash used in operating activities $(84,089) thousand; purchase of property and equipment $(16,708) thousand; free cash flow $(100,797) thousand
- Year-to-date stock-based compensation expense $33,256 thousand; depreciation, accretion and amortization $29,931 thousand
- Warrant liability $0 at October 4, 2026 (December 28, 2025: $6,578 thousand); year-to-date change in fair value of common stock warrants $6,578 thousand (GAAP gain)
- Year-to-date repayment of debt $(1,696) thousand
- Company states the $512.2 million cash balance reflects $6.2 million of Q3 repurchases and precedes the October and November 2026 repurchases of 2030 Notes and common stock
Analysis
Enovix reported Q3 2026 revenue of $11,039 thousand, up 38% from Q3 2025 and 22% from Q2 2026, which the company describes as its sixth consecutive quarter of year-over-year revenue growth. Non-GAAP gross margin was 34.5%, against 21.0% a year earlier, and GAAP gross margin was 30.1% against 17.5%. The company attributes the higher gross margin to a richer revenue mix that includes smart eyewear and drone and defense revenue. Non-GAAP loss from operations was $(29,215) thousand against $(29,825) thousand, and GAAP loss from operations narrowed to $(39,294) thousand from $(46,973) thousand. GAAP operating expenses fell to $42,622 thousand from $48,374 thousand, while non-GAAP operating expenses rose to $33,018 thousand from $31,506 thousand. Non-GAAP net loss per diluted share was $(0.15) against $(0.14).
Cash flow moved the other way. Net cash used in operating activities was $(29.2) million against $(25.5) million, and free cash flow was $(33.1) million against $(28.5) million. Year to date, free cash flow was $(100.8) million against $(85.5) million. The company reports cash, cash equivalents, marketable securities and restricted cash of $512,159 thousand at October 4, 2026, before October and November repurchases. Total equity on the balance sheet fell to $171,143 thousand from $274,011 thousand at December 28, 2025, and total assets fell to $754,973 thousand from $878,975 thousand.
The demand picture in the filing centres on drone and defense. The company reports a drone, defense and industrial pipeline of approximately $216 million, up 18% from $183 million, with drones at $150 million. It also reports a 100,000-battery order for conventional cells and an initial production order for MX1-B01 cells with deliveries scheduled in early 2027. Pipeline and design wins are defined in the filing as not constituting orders, backlog or committed revenue. Smartphone is the weak point: the AI-1 cell did not meet the latest energy-density target on the pre AI-2 version, and the company stopped system-level field testing with those units while concentrating silicon-anode development on smart eyewear.
Q4 2026 guidance calls for revenue of $9.0 – 10.0 million, a printed year-over-year decline of (20%) – (12%) against $11.3 million, and a non-GAAP loss from operations of ($28.0 – 31.0) million. FY 2027 revenue guidance of $65.0 – 85.0 million is presented against a FY 2026 estimate of $36.7 – 37.7 million, which the filing says is year-to-date revenue plus Q4 guidance. The company says nearly half the FY 2027 midpoint is already in backlog. The company also states that the November restructuring, with 220 positions removed, cuts approximately $8.5 million of annual cost. The filing reports no prior outlook, so no comparison of guidance against earlier targets is made here.
Capital allocation was active. The company repurchased $6.2 million of stock in Q3 2026 and $15.5 million in October, and retired $128.0 million face value of 2030 Notes for approximately $81.4 million, leaving $232.0 million outstanding. The warrant dividend, with a $3.00 strike and expiry on April 28, 2028, is designed to retire the 2028 Notes. The filing states that the 2030 Notes repurchase will produce a gain in GAAP results but not in non-GAAP results.
Management, verbatim
Enovix is aligning its resources and cost structure with our strongest near-term opportunities.
Ryan Benton, Interim CEO
Our customers need high-performance cells from a qualified, non-Chinese source, and they need them in volume next year.
Steve Bakos, Chief Revenue Officer and General Manager
In our August press release I promised shareholders to reduce our expenses and to make our reports to investors more candid and transparent. This report is our first effort to move toward those standards.
T.J. Rodgers, Executive Chairman
Not in the filing
stated, not guessed- Segment or product-line revenue split (the filing gives no revenue breakdown by segment; the drone, defense and industrial figure is a pipeline measure, not revenue)
- Prior-year and prior-quarter figures for Q3 2026 GAAP net loss per share change and Q3 2026 GAAP net loss attributable percentage change
- Prior-quarter (Q2 2026) figures for every Q3 2026 metric other than revenue growth percentage stated in the letter
- Q3 2026 standalone cash flow statement (only year-to-date cash flow statement is presented; quarterly cash flow lines are taken from the financial summary)
- Quarterly GAAP cash and cash equivalents comparison to the prior quarter end
- Income tax benefit and interest expense year-over-year change figures for Q3 2026
- Prior-year balance for total debt and the number of shares outstanding at Q3 2025
- Any prior-period outlook (the filing does not include the previous release's outlook, so no vs_prior_guidance comparison is possible)
- Consensus estimates, analyst expectations and share-price reaction (not in the filing)
- Breakdown of the gross margin change into price, volume and mix (the company gives only a qualitative explanation)
- Quantified split of restricted cash within the $512,159 thousand cash balance
- Q4 2026 gross margin, operating expense and tax rate guidance (not provided)
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Enovix Corp (NASDAQ: ENVX) filed a Form 8‑K reporting Q3'26 financials and FY2027 revenue guidance.
Ticker impact
Enovix reported Q3'26 results with a record non-GAAP gross margin of 34.5% and issued FY2027 revenue guidance of $65 million to $85 million.
likely upward pressure as the market prices in the issued revenue outlook
Guidance expansion to $85M at the midpoint nearly doubles the prior year outlook, providing a fresh catalyst for the stock.
Market effects
May lift sentiment for the advanced lithium‑ion battery and energy‑storage sector.
Impacts US micro‑cap investors focused on emerging battery technologies.
Limited to niche battery market; broader market effect is modest.
Counterpoint
Guidance could be overly optimistic given ongoing cash burn and high operating expenses.
Key entities
- companyEnovix Corp
Developer and manufacturer of advanced lithium‑ion batteries.
